Millennium Management’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
Other funds holding PACB
AIM
VCM
NAMA
Millennium Management's PACB Position: Q1 2026 in Review
Millennium Management increased its Pacific Biosciences (PACB) stake by 13% in Q1 2026, buying an estimated $980K and bringing the position to 4,892,318 shares worth $6.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2650.
Millennium Management first reported a position in PACB in Q2 2013 and has held it in 50 quarters since. The position peaked at $38.3M in Q4 2020. 229 funds tracked by Wall St. Rank hold PACB as of Q1 2026.
- Millennium Management held 4,892,318 shares of Pacific Biosciences worth $6.46M as of Q1 2026.
- Millennium Management bought 547,749 Pacific Biosciences shares in Q1 2026, an estimated $980K.
- Pacific Biosciences made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2650 holding.
- Millennium Management first reported a position in Pacific Biosciences in Q2 2013 and has held it in 50 quarters since.
- Millennium Management's Pacific Biosciences position peaked at $38.3M in Q4 2020.
- 229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.